NCT01777529View on ClinicalTrials.gov

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations

PHASE4CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

December 31, 2013

Conditions

MeaslesMumpsRubella

Interventions

BIOLOGICAL

MMR Vaccine

Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKline

Trial Locations (1)

Unknown

CMS Heitor Beltrão, Rio de Janeiro

All Listed Sponsors

lead

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

OTHER

NCT01777529 - Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations | Biotech Hunter | Biotech Hunter